LOCALLY ADVANCED BREAST CANCER (LABC)
Clinical trials for LOCALLY ADVANCED BREAST CANCER (LABC) explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED BREAST CANCER (LABC) trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED BREAST CANCER (LABC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced breast cancer patients as trial tests novel drug combos
Disease control Recruiting nowThis study is testing several combination treatments involving the experimental drug FWD1802 for people with advanced ER-positive/HER2-negative breast cancer that has spread or cannot be removed by surgery. The research aims to find safe doses and see if these combinations can he…
Matched conditions: LOCALLY ADVANCED BREAST CANCER (LABC)
Phase: PHASE1, PHASE2 • Sponsor: Forward Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test 'Switchable' cell therapy to fight advanced breast cancer
Disease control Recruiting nowThis is an early study to test the safety of a new two-part treatment for people with advanced breast cancer that has spread or cannot be removed by surgery. The treatment involves giving patients their own modified immune cells (CLBR001), followed by a biologic drug (ABBV-461) t…
Matched conditions: LOCALLY ADVANCED BREAST CANCER (LABC)
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC